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Abstract
There may be a pathological connection between cardiac failure and ischemic stroke. In this article we describe pertinent
research that demonstrates subsequent death of cardiac and neural myocytes in the post ischemic stroke brain. Current
stroke therapy overlooks the connection between cardiac and cerebrovascular events and fails to address the shared risk
factors. Current pre-clinical stroke investigations have provided evidence that suggests the presence of an indirect cell
death pathway in which toxic molecules emanate from the stroke brain and trigger cardiac cell death. On the other
hand, other studies highlight the presence of a reverse cell death cascade in which toxic molecules from the heart,
following cardiac arrest, travel to the brain and induce ischemic cell death. Further examination of these putative cell
death pathways between ischemic stroke and cardiac arrest will prompt the advancement of innovative treatments
specifically targeting both diseases, leading to ameliorated clinical results of patients diagnosed with heart failure and
ischemic stroke.
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Background
Stroke and cardiovascular disease are two of the principle
causes of death in the world. In total, the United States
allots $260.7 billion to address both cerebrovascular and
cardiac disease every year [1, 2]. The two diseases share
several predisposing factors including obesity, diabetes,
hypertension, high cholesterol, and family history of heart
disease [3–6]. It is worth noting that 2–6 % of all deaths
originating from a cardiac condition took place roughly
3 months following a cerebral infarction [7, 8]. This calcu-
lation is reinforced by evidence that demonstrates a higher
likelihood of cardiac death following ischemic stroke. Data
show that following an ischemic stroke, the patient’s body
has increased volumes of plasma catecholamines and
cardiac enzymes [7, 8]. This increase in cardiac enzymes is
coincident with increased levels of troponin and creatine
phosphokinase, which are a signal of stress or death in
cardiac cells [7, 8]. In addition, the elevated level of cat-
echolamine is linked to high blood pressure under stressful
conditions. [9–11]. Furthermore, inflammation following
ischemic stroke is also indicative of a pathological pathway
connecting the brain and the heart. C-reactive protein
(CRP), which is elevated during periods of inflammation
within the body, was the specific factor found to be associ-
ated with the risk of new cardiovascular events in stroke
patients [12], in thatpatients with higher levels of CRP fol-
lowing ischemic stroke isplayed 36 % greater risk of a new
cardiovascular event [12]. This implicates inflammation as
a key factor in the cascading effect of harmful substances
from the stroke brain to the cardiovascular system.
Although the association between cardiac and cerebro-
vascular events has been made apparent, clinics continue
to overlook the correlations between the two. Regrettably,
up to 88 % of all patients who suffer from an ischemic
stroke display cardiac symptoms within 4 weeks after the
stroke [13]. Ischemic damage in the insular cortex yields
the highest occurrence of cardiac death in comparison to
other regions of the brain [13]. While it is widely accepted
that the insular cortex preludes cardiac myocyte death, it
has yet to be determined whether myocyte death is caused
by a sub-region or the entire insular cortex. As a result,
the connection between the insular cortex and heart
disease has yet to be firmly established.
Aware of the correlation between cardiac failure and
ischemic stroke, we decided to observe the connection
between neural cell death after ischemic stroke and cardiac
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myocyte compromise, utilizing both in vitro and in vivo
stroke models [14]. In the in vitro study, we applied the
method of oxygen-glucose deprivation (OGD) to primary
rat neuronal cells (PRNCs), determining cellular alter-
ations in rat cardiac myocytes (RCMs) after the ischemic-
reperfusion injury using the supernatant. For the in vivo
study, transient middle cerebral artery occlusion (MCAo)
was used in adult rats. Immunohistochemical analyses
were performed on both the hearts and brains of the rats
to determine the various cell death markers. We predicted
that the release of cell death factors by the ischemic brain
would result in cardiac myocyte compromise. These re-
sults demonstrated that cerebral infarction cascaded cell
death signals upon the heart (Fig. 1) [14]. Our results from
the in vitro study revealed that the PRNCs caused toxic
effects in the RCMs. The in vivo study supported these
findings, revealing that animals subject to ischemic stroke
experienced RCM cell death. These findings suggest a
close pathological link between cerebral ischemia and car-
diac arrest.
Several conditions, including cerebral ischemia and car-
diac failure, have been linked to other major neurological
disabilities across the globe. Situations where both cere-
bral and cardiac conditions develop concurrently result in
high mortality rates [15]. Our recent investigation demon-
strated cardiac myocyte death following cerebral ischemia,
further supporting the assertion that ischemic stroke can
possibly result in cardiac complications [14]. Physical
symptoms can be indicative of a detrimental effect on car-
diac function immediately following the cerebrovascular
event, which may predict the occurrence of a myocardial
infarction [16]. Indeed, 5.7 % of patients presented with
arterial fibrillation or flutter within 5 days of stroke [16]
suggesting that the stroke brain and the corresponding
heart dysfunctions may be pathologically linked.
These findings prompt the question “How does ische-
mic stroke interrupt normal cardiac function?” Although
the brain is responsible for controlling the heart rate,
the mechanism of beating occurs naturally. When the
brain is subjected to ischemic stroke, its ability to con-
trol heart rhythm is disrupted, directly compromising
the heart [8, 13]. As previously noted, the insular cortex
of the brain is the region primarily responsible for
controlling the heart rate [17]. Collectively, these obser-
vations suggest a crosstalk between the heart and insu-
lar cortex shortly after cerebral ischemia.
Shockingly, our findings revealed that the induced direct
ischemia/reperfusion (I/R) damage to the RCMs in fact
had no impact on cardiac myocyte death [14]. After adding
the OGD supernatant, our results from the in vitro study
demonstrated massive cardiac cell death, suggesting that
an indirect pathway originating from the area of cerebral
ischemia and involving brain-mediated cell death signals
was responsible for the observed cardiac changes. While
solid evidence has been found, it is necessary to consider
other possible parallel cell death pathways that connect
cardiac cell death and ischemic stroke, such as neuro-
endocrine mediated myocardial suppression [7, 18], sys-
temic responses [6, 19, 20], and alterations in circulating
endothelial progenitor cells [21].
Further immunocytochemical evaluations demonstrated
that OGD-exposed PRNCs displayed a substantial time-
dependent proliferation of positive cells against all cell
death markers 24 h after I/R damage in comparison to the
control group [14]. Furthermore, cerebral ischemic events
significantly modified the autophagic pathway rather than
the necrotic and apoptotic cell death mechanisms, creating
toxic effects to the heart [14], suggesting that autophagy-
related cell death signals could be primarily responsible for
cardiac injury following stroke.
More in depth examination of our in vivo findings
revealed that both the heart and brain also displayed all
the death cell markers of necrosis, autophagy, and apop-
tosis [14]. In addition, not only were apoptotic and
autophagic cells identified in the ipsilateral side, but also
on the contralateral side. These findings indicate that
Fig. 1 Cell death factor cascade represents the pathological link between
the brain and the heart. Ischemic stroke can lead to detrimental effects on
the heart. Cardiac arrest can also release cell death factors to the brain
potentially leading to ischemic stroke
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while the initial injury was contained within one hemi-
sphere, the damage can spread globally to the rest of the
brain as the disease progresses, and can possibly reach
the heart.
Oppenheimer and Hachinski advanced the idea of the
lateralization of stroke resulting in cardiac complications
[7] and it continues to be a very prevalent topic for re-
searchers [22]. In normal humans, lateralization of cardio-
vascular autonomic function has been demonstrated in the
forebrain, notably injury to the insular cortex correlates
with more prominent autonomic imbalance, leading to ar-
rhythmias and even sudden death [23]. In connection, the
knowledge that left-handers have a lower possibility of
sudden death in comparison to right handers [23] implies
that an ischemic stroke to the right hemisphere is more
responsible for arrhythmias than a stroke to the left hemi-
sphere. While a comparable lateralization model has been
demonstrated in insular epilepsy-dysphoric responses were
statistically related to stimulation in the right hemisphere
rather than stimulation in the mesial frontal, orbitofrontal,
mesial temporal, and insular stimulation sites in the left
hemisphere [24]—it has also been disputed in studies on
ictal bradycardia, an occurrence associated with bilateral
hemispheric seizure activity instead of a lateralized sign that
localizes seizure onset. These findings challenge the notion
that a primarily unilateral parasympathetic cardiomotor
representation exists in the left hemisphere [25].
In extreme ischemic events, brain natriuretic peptide
(BNP), which acts as a biomarker that correlates with
high mortality rates, levels can be raised [26]. BNP is
released by cardiac muscle under increased amounts of
stress and is linked to a defect in the left ventricle as
well as the severity of the defect. It also participates in
natriuresis and vasodilation, decreasing systolic blood
pressure [26]. In ischemic stroke, it has been shown that
all-cause mortality is linked to BNP and N-terminal-pro-
brain natriuretic peptide (NT-proBNP), as well as being
closely associated with cardio-embolic stroke. This evi-
dence suggests that the kidney, along with the heart, is
connected with stroke pathology. Along with all-cause
mortality in ischemic stroke, transient ischemic attack
(TIA) or hemorrhagic stroke is associated with an elevation
of NT-proBNP and BNP levels, conveying a relationship
between the heart and ischemic stroke. Altogether, these
investigations suggest that an elevation of BNP levels is
related to a worse outcome after stroke [27]. In addition,
these studies reveal that renal failure is connected to an
increase of NT-proBNP and BNP, both functioning as inde-
pendent predictors of death due to kidney failure and as
risk factors for ischemic stroke together with cardiac failure.
The idea that an indirect pathological pathway of cell
death exists, initiating in the brain and concluding in the
heart, suggests that there must be soluble molecules that
are produced by the ischemic brain cells that could carry
cell death signals to cardiac myocytes. However, these
toxic molecules have yet to be determined. In addition,
as these toxins move through the cardiovascular system,
it is necessary to conduct investigations regarding their
effects on vital peripheral organs. At its most basic of
assertions, our study [14] suggests that a cardiac exam
should be considered following an ischemic stroke and
could potentially be integrated into standard clinical
stroke treatment and management.
That cerebral ischemia may result in cardiac myocyte
death, complements a series of investigations that show
the reverse interaction, whereby heart events lead to
stroke-like brain pathology [15, 28–30]. A biological cross-
talk involving the brain and the heart is corroborated by
evidence demonstrating cardiac events result in a stroke-
like brain pathology. The exact biological mechanisms and
specific pathways linking myocardial infarction and brain
damage are not fully understood, but accumulation of
intracellular calcium, mitochondrial overload, and impaired
ATP production have been observed in neuronal cell death
following cardiac arrest [31]. Most notably, inflammatory
mechanisms similarly play a large part in post-cardiac arrest
leading to cerebral injury. Following myocardial infarction,
the immune-privileged microenvironment that exists in the
brain is disrupted and characterized by activation of micro-
glia, migration of nearby macrophages and neutrophils, as
well as the release of pro-inflammatory cytokines [32].
Conclusions
The merging of these studies on cardiac arrest and
ischemic stroke strongly implies the presence of a patho-
logical pathway connecting these two diseases (Fig. 1).
Further investigations and understanding of overlapping
molecular, cellular, and anatomical alterations seen in
heart failure and ischemic stroke will guide the develop-
ment of innovative treatment strategies focused on com-
batting both diseases, which will likely lead to improved
clinical outcomes of patients afflicted with both illnesses.
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